SEC Form 4 · accession 0001225208-15-012977
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Heino Lennartz
Officer — President Europe
Period of report
Feb 26, 2015
Accepted (ET)
May 29, 2015 · 11:48 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2015 | S | 1,000 | $54.8326 | D | 20,877 | D | |
| Common Stock | May 28, 2015 | S | 2,000 | $54.8801 | D | 18,905 | D | |
| Common StockF1 | May 28, 2015 | S | 6,584 | $55.0582 | D | 12,321 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.